Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Self-sampling for cervical cancer screening tested in 7,100-person study

NCT ID NCT06843720

Knowledge-focused Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to improve access to cervical cancer screening by using self-collection for HPV testing in safety net health systems. Researchers will interview patients, providers, and stakeholders to understand attitudes and develop training materials. The trial enrolls 7,100 participants and focuses on implementation rather than a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that self-collection for HPV testing is a practical way to increase cervical cancer screening in underserved communities.
What could go wrong
This is an observational/behavioral study, not a treatment trial. It focuses on implementation and attitudes, not on curing disease, so direct health benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 7,100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Mar 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Populations involved in the research are: 1. stakeholder advisory board members; 2. patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial; 3. patients and community members participating in formative research activities; 4. providers, clinic staff, and other health system stakeholders from partnering health systems; 5. Project ECHO Participants (providers, clinic staff, and other health system stakeholders from partner and non-partner institutions); 6. Other Clinical Networks (providers, clinic staff and other health system stakeholders from partner and non-partner institutions) The eligibility criteria for each are: Patients eligible for cervical cancer screening: * Currently a resident in the state of Texas * Attend for care at a partner clinic enrolled in the study * Women and persons with a cervix * Age 25-65 * Due or past due for cervical cancer screening Patients and community members participating in formative research activities: • Purposively identified as a stakeholder for formative research by research staff Providers, clinic staff, and other health system stakeholders from partnering health systems: * Employed at least part-time by a partnering health system * Age 18+ Project ECHO Participants: * Participate in at least one Project ECHO session * Age 18+ Other Clinical Networks: * Participate in at least one clinical network session * Age 18+ Exclusion Criteria: Patients eligible for cervical cancer screening: * Report being currently pregnant * History of total hysterectomy * History of cervical cancer Other study populations: • Unable to communicate in English or Spanish Vulnerable Populations Participants/samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults, or prisoners) will be prohibited from participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HR-HPV testing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HR-HPV testing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States